References
- Litvak K M, McEvoy G K. Ketorolac, an injectable nonnarcotic analgesic. Clin Pharm 1990; 9: 921–935
- Toradol product monograph. Syntex Laboratories, Inc., Palo Alto, CA 1990
- Clive D M, Stoff J S. Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1984; 310: 563–572
- Hart D, Lifschitz M D. Renal physiology of the prostaglandins and the effects of nonsteroidal anti-inflammatory agents on the kidney. Am J Nephrol 1987; 7: 408–418
- Whelton A, Hamilton C W. Nonsteroidal anti-inflammatory drugs: effects on kidney function. J Clin Pharmacol 1991; 31: 588–598
- Blackshear J L, Davidman M, Stillman M T. Identification of risk for renal insufficiency from nonsteroidal anti-inflammatory drugs. Arch Intern Med 1983; 143: 1130–1134
- Dibona G F. Prostaglandins and nonsteroidal anti-inflammatory drugs. Effects on renal hemodynamics. Am J Med 1986; 80(Suppl 1A): 12–21
- Dunn M J, Scharschmidt L, Zambraski E. Mechanisms of the nephrotoxicity of non-steroidal anti-inflammatory drugs. Arch Toxicol Suppl 1984; 328–337
- Muther R S, Bennett W M. Effects of aspirin on glomerular filtration rate in normal humans. Ann Intern Med 1980; 92: 386–387
- Boras-Uber L A, Brackett N C. Ketorolac-induced acute renal failure. Am J Med 1992; 92: 450–452